TELCON RF PHARMACEUTICAL. Inc. (KOSDAQ:200230)
South Korea flag South Korea · Delayed Price · Currency is KRW
636.00
-3.00 (-0.47%)
Apr 29, 2026, 3:30 PM KST

TELCON RF PHARMACEUTICAL. Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Operating Revenue
43,16237,86536,30727,83037,841
Upgrade
Other Revenue
---0--0
Upgrade
Revenue
43,16237,86536,30727,83037,841
Upgrade
Revenue Growth (YoY)
13.99%4.29%30.46%-26.46%14.18%
Upgrade
Cost of Revenue
33,04227,62826,80022,26728,780
Upgrade
Gross Profit
10,12010,2379,5075,5639,061
Upgrade
Selling, General & Admin
5,9786,2524,4844,5546,949
Upgrade
Research & Development
699.14722.94733.171,2081,635
Upgrade
Amortization of Goodwill & Intangibles
2,5042,5482,5652,5822,597
Upgrade
Other Operating Expenses
253.11112.5459.7668.03168.3
Upgrade
Operating Expenses
9,40110,3078,5429,62613,624
Upgrade
Operating Income
718.59-70.55965.32-4,063-4,563
Upgrade
Interest Expense
-4,813-3,760-603.58-1,063-7,702
Upgrade
Interest & Investment Income
682.02324.97205.0561.4245.48
Upgrade
Earnings From Equity Investments
-3,222-24,684469.53-17,868-13,196
Upgrade
Currency Exchange Gain (Loss)
-125.74602.71119.08318.02831.71
Upgrade
Other Non Operating Income (Expenses)
2,3401,119-837.92-1,98177.32
Upgrade
EBT Excluding Unusual Items
-4,420-26,468317.48-24,595-24,507
Upgrade
Gain (Loss) on Sale of Investments
-5,8171,27513,466-13,1464,626
Upgrade
Gain (Loss) on Sale of Assets
-17.27-14.834.3810.31
Upgrade
Asset Writedown
-1,324-1,097-64.8-4,411-3,005
Upgrade
Other Unusual Items
130.12-227.31244.63--
Upgrade
Pretax Income
-11,431-26,50013,949-42,117-22,875
Upgrade
Earnings From Continuing Operations
-11,431-26,50013,949-42,117-22,875
Upgrade
Earnings From Discontinued Operations
-----331.42
Upgrade
Net Income to Company
-11,431-26,50013,949-42,117-23,207
Upgrade
Minority Interest in Earnings
-24.35180.11-42.3432.81108.8
Upgrade
Net Income
-11,456-26,32013,906-42,084-23,098
Upgrade
Net Income to Common
-11,456-26,32013,906-42,084-23,098
Upgrade
Shares Outstanding (Basic)
4835343226
Upgrade
Shares Outstanding (Diluted)
4835454126
Upgrade
Shares Change (YoY)
35.13%-20.94%8.89%56.33%2.65%
Upgrade
EPS (Basic)
-239.00-742.00414.65-1322.39-876.43
Upgrade
EPS (Diluted)
-239.00-742.00341.71-1322.39-876.43
Upgrade
Free Cash Flow
1,347-3,749-4,954-2,912-2,613
Upgrade
Free Cash Flow Per Share
28.10-105.69-110.43-70.69-99.13
Upgrade
Gross Margin
23.45%27.03%26.19%19.99%23.95%
Upgrade
Operating Margin
1.67%-0.19%2.66%-14.60%-12.06%
Upgrade
Profit Margin
-26.54%-69.51%38.30%-151.22%-61.04%
Upgrade
Free Cash Flow Margin
3.12%-9.90%-13.64%-10.46%-6.90%
Upgrade
EBITDA
5,5434,4365,210218.47-363.07
Upgrade
EBITDA Margin
12.84%11.72%14.35%0.78%-0.96%
Upgrade
D&A For EBITDA
4,8244,5074,2444,2814,200
Upgrade
EBIT
718.59-70.55965.32-4,063-4,563
Upgrade
EBIT Margin
1.67%-0.19%2.66%-14.60%-12.06%
Upgrade
Advertising Expenses
13.1935.0610.7745.183.36
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.